News

Royal Brompton and Harefield hospitals have been named as performing “better than expected” in the Care Quality Commission’s 2019 Adult Inpatient Survey. For the survey, which covers different aspects of care and treatment, the CQC looked at the experiences of more than 654 patients who stayed in our hospitals. The Trust was named better than other trusts in eight of the 11 areas covered. Read more

The pulmonary rehabilitation team at Harefield Hospital has become the first service in the country to receive full accreditation in a scheme run by the Royal College of Physicians (RCP) in association with the British Lung Foundation and the British Thoracic Society. Launched in 2018, the Pulmonary Rehabilitation Services Accreditation Scheme (PRSAS) aims to improve the quality of pulmonary rehabilitation services throughout the UK. Read more

NHS England has today announced that NHS patients in England will be some of the first people in Europe to benefit from a new treatment for cystic fibrosis (CF). Three in five patients with the genetic condition could benefit from the ‘triple combination’ treatment produced by Vertex Pharmaceuticals, called ‘Kaftrio’, or ‘Trikafta’ in the US. The treatment tackles the underlying causes of CF by helping the lungs work effectively. Read more

Covid-19 patient Sam McQueen was transferred to Royal Brompton Hospital from Northwick Park Hospital on 22 March with severe Covid-19 related lung disease. In this moving video Sam shares his struggles battling Covid-19: from time on Royal Brompton Hospital’s Adult Intensive Care Unit, to gaining use of his hands and legs again, to the ‘infusion of energy’ he received at the thought of going home, and his gratitude to the NHS for saving his life. Watch video